Video Experimental Relacionado
Updated: May 19, 2026
08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Nanocápsulas de un solo siRNA para la entrega mejorada de RNAi
Ming Yan1, Min Liang, Jing Wen
1Department of Microbiology, Immunology, and Molecular Genetics, and California NanoSystems Institute (CNSI), University of California, Los Angeles, California 90095, USA.
Journal of the American Chemical Society
|August 8, 2012
Resumen
Este estudio presenta una nueva nanocápsula para la entrega de moléculas individuales de ARN pequeño interferente (siRNA), mejorando la estabilidad y la absorción celular para posibles aplicaciones terapéuticas en el tratamiento de enfermedades.
Área de la Ciencia:
- Biotecnología La biotecnología es la biotecnología.
- Nanotecnología La nanotecnología es la nanotecnología.
- Biología Molecular Biología Molecular
Sus antecedentes:
- El ARN pequeño interferente sintético (siRNA) muestra una promesa terapéutica, pero se enfrenta a desafíos en la estabilidad y la entrega.
- La administración efectiva de compuestos de interferencia de ARN (RNAi) a los tejidos y células objetivo sigue siendo un obstáculo significativo para la traducción clínica.
Objetivo del estudio:
- Desarrollar y validar un nuevo sistema de administración basado en nanocápsulas para moléculas de siRNA individuales.
- Para demostrar la eficacia de este sistema en la regulación a la baja de objetivos genéticos específicos, utilizando CCR5 como modelo para la terapia del VIH.
Principales métodos:
- Encapsulación de moléculas individuales de siRNA dentro de nanocápsulas de polímero degradables (aprox. 20 nm de diámetro, carga superficial positiva).
- Entrega de nanocápsulas de CCR5-siRNA en las células 293T para evaluar la regulación a la baja del ARN CCR5.
- Evaluación de la estabilidad de la nanocápsula y la integridad del siRNA en presencia de RNasa y suero humano.
- Comparación de la eficiencia del silenciamiento de genes con el siRNA libre y la administración mediada por lipofectamina.
Principales resultados:
- Las nanocápsulas entregaron con éxito CCR5-siRNA, regulando a la baja la expresión del ARN CCR5 al 8% en 293 células T.
- Las nanocápsulas protegen el siRNA de la degradación por RNasa y el suero, manteniendo la integridad durante 1 hora.
- En el suero, el siRNA suministrado por la nanocápsula logró <15% de expresión CCR5-mCherry, superando significativamente a la lipofectamina (55%).
Conclusiones:
- Se ha desarrollado una nueva plataforma de entrega de nanocápsulas de un solo siRNA.
- Esta tecnología ofrece una mayor estabilidad y un silenciamiento genético efectivo, abordando las limitaciones clave de las terapias actuales de siRNA.
- La plataforma de nanocápsulas tiene potencial para el desarrollo terapéutico en diversas enfermedades humanas.
Videos de Conceptos Relacionados
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...